XOMA Royalty Corp. (XOMA) Cash Flow Statement

The frequent divergence between net income and operating cash flow suggests that GAAP earnings are heavily influenced by non-cash fair value adjustments rather than actual cash receipts. Investors should monitor this disconnect, as it implies that reported profitability may not be a reliable proxy for the company's ability to fund its ongoing operations.

The lack of a consistent positive FCF trend suggests that the business model is currently in a capital-intensive phase where cash generation is insufficient to cover both operating overhead and portfolio expansion. This volatility warrants further investigation into whether the company can achieve sustainable cash self-sufficiency without further dilutive financing.

These fluctuations appear to be driven by the timing of milestone receipts from pharmaceutical partners, which are inherently binary and difficult to forecast. The resulting instability in working capital may force management to maintain higher cash buffers than would otherwise be necessary for a more stable royalty aggregator.

The company's decision to maintain dividend payments while operating cash flow is negative suggests a management focus on signaling stability to investors. However, this strategy may limit the capital available for opportunistic asset acquisitions, potentially slowing the long-term growth of the royalty portfolio.